FWM
GILD icon

Focused Wealth Management’s Gilead Sciences GILD Stock Holding History

Focused Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,000
Closed -$19K – 969
2021
Q1 		$19K Buy
+8,000
New +$516K ﹤0.01% 508
2018
Q2 		– Sell
-11,000
Closed -$7K – 692
2018
Q1 		$7K Buy
+11,000
New +$874K ﹤0.01% 519
2017
Q4 		– Sell
-10,000
Closed -$5K – 707
2017
Q3 		$5K Buy
+10,000
New +$765K ﹤0.01% 512
2015
Q4 		– Hold
0
– -$767K – 689
2015
Q3 		– Hold
0
– – – 40

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Focused Wealth Management's GILD Position: Q1 2024 in Review

Focused Wealth Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 1,114 shares — an estimated $90.3K sold.

Focused Wealth Management first reported a position in GILD in Q2 2014 and held it in 39 quarters. The position peaked at $2.02M in Q3 2017. 1,721 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Focused Wealth Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 1,114 Gilead Sciences shares in Q1 2024, an estimated $90.3K.
  • Focused Wealth Management first reported a position in Gilead Sciences in Q2 2014 and held it in 39 quarters.
  • Focused Wealth Management's Gilead Sciences position peaked at $2.02M in Q3 2017.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.